1
Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma
Condition(s):LymphomaLast Updated:January 12, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:January 12, 2021Terminated
Condition(s):Microscopic ColitisLast Updated:April 15, 2021Recruiting
Condition(s):Non-small Cell Lung Cancer; Radiation ToxicityLast Updated:January 31, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.